Cleveland BioLabs Announces $4.2 Million Financing – MarketWatch

Cleveland BioLabs Announces $4.2 Million Financing
MarketWatch
In addition, a total of 1,406,062 Series A Warrants to purchase shares of common stock at an exercise price of $3.64 per share were issued in a private placement, which shall be initially exercisable six months following issuance and expire six years

and more

…read more

Scroll to Top